Serbia vs Georgia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 84% | 90% |
| 2023 | 84% | 95% |
| 2022 | 81% | 90% |
| 2021 | 75% | 90% |
| 2020 | 78% | 91% |
| 2019 | 87% | 99% |
| 2018 | 93% | 98% |
| 2017 | 86% | 95% |
| 2016 | 82% | 93% |
| 2015 | 87% | 96% |
| 2014 | 86% | 92% |
| 2013 | 92% | 97% |
| 2012 | 87% | 93% |
| 2011 | 93% | 91% |
| 2010 | 95% | 94% |
| 2009 | 95% | 83% |
| 2008 | 92% | 97% |
| 2007 | 95% | 97% |
| 2006 | 88% | 96% |
| 2005 | 96% | 90% |
| 2004 | 89% | 86% |
| 2003 | 87% | 76% |
| 2002 | 92% | 75% |
| 2001 | 90% | 74% |
| 2000 | 89% | 73% |
| 1999 | 84% | 76% |
| 1998 | 88% | 73% |
| 1997 | 92% | 69% |
| 1996 | 90% | 65% |
| 1995 | 86% | 61% |
| 1994 | 81% | 63% |
| 1993 | 85% | 61% |
| 1992 | 82% | 16% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 95% | 86% |
| 2023 | 93% | 88% |
| 2022 | 92% | 85% |
| 2021 | 91% | 85% |
| 2020 | 92% | 88% |
| 2019 | 97% | 94% |
| 2018 | 97% | 93% |
| 2017 | 95% | 91% |
| 2016 | 93% | 92% |
| 2015 | 95% | 94% |
| 2014 | 93% | 91% |
| 2013 | 95% | 93% |
| 2012 | 91% | 92% |
| 2011 | 94% | 94% |
| 2010 | 91% | 92% |
| 2009 | 95% | 88% |
| 2008 | 95% | 92% |
| 2007 | 94% | 98% |
| 2006 | 92% | 88% |
| 2005 | 98% | 82% |
| 2004 | 88% | 78% |
| 2003 | 89% | 75% |
| 2002 | 95% | 84% |
| 2001 | 93% | 87% |
| 2000 | 95% | 80% |
| 1999 | 92% | 84% |
| 1998 | 93% | 80% |
| 1997 | 94% | 80% |
| 1996 | 91% | 80% |
| 1995 | 89% | 79% |
| 1994 | 85% | 58% |
| 1993 | 85% | 54% |
| 1992 | 84% | 58% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 93% | 90% |
| 2023 | 93% | 93% |
| 2022 | 92% | 85% |
| 2021 | 89% | 85% |
| 2020 | 87% | 88% |
| 2019 | 94% | 94% |
| 2018 | 91% | 93% |
| 2017 | 93% | 91% |
| 2016 | 91% | 92% |
| 2015 | 94% | 94% |
| 2014 | 92% | 91% |
| 2013 | 91% | 96% |
| 2012 | 97% | 92% |
| 2011 | 94% | 89% |
| 2010 | 89% | 95% |
| 2009 | 93% | 54% |
| 2008 | 93% | 89% |
| 2007 | 99% | 94% |
| 2006 | 93% | 84% |
| 2005 | 65% | 79% |
| 2004 | 89% | 64% |
| 2003 | - | 48% |
| 2002 | - | 51% |
| 2001 | - | 61% |
| 2000 | - | 55% |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 84% of children aged 12–23 months in Serbia and 90% in Georgia: 6 percentage points more in Georgia. The third DTP dose reaches 95% in Serbia and 86% in Georgia, 9 points more in Serbia. The third hepatitis B dose reaches 93% in Serbia and 90% in Georgia, 3 points more in Serbia. In 1992, the first measles dose reached 82% in Serbia and 16% in Georgia, 66 percentage points more in Serbia.
Serbia vs Georgia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 84% (2024) | 90% (2024) |
| DTP3 | 95% (2024) | 86% (2024) |
| HepB3 | 93% (2024) | 90% (2024) |
Serbia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Georgia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Serbia and its seven neighbors, the latest coverage of the first measles dose is highest in Hungary, at 99%, and lowest in Montenegro, at 23%; of Georgia and its four neighbors, the latest coverage of the first measles dose is highest in Russia, at 97%, and lowest in Azerbaijan, at 71%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.